Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SENTI BIOSCIENCES, INC.

(SNTI)
  Rapport
Geschatte realtime Cboe BZX  -  21:09:53 27-01-2023
1.755 USD   -10.00%
2022Senti Biosciences, Inc. : JPMorgan Chase verlaagt advies naar Neutraal
MM
2022Senti Biosciences, Inc. Benadrukt preklinische gegevens van Logic-Gen-Circuit CAR-NK celtherapie SENTI-202 op ASH Annual Meeting en Investor Event.
CI
2022Senti Biosciences, Inc. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2022
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op SENTI BIOSCIENCES, INC.
14:01Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Upd..
13:39Senti Biosciences : Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell The..
13:28Senti Biosciences, Inc. : Regulation FD Disclosure, Other Events, Financial Statements and..
09/01Senti Biosciences, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
2022Senti Bio to Present at 41st Annual J.P. Morgan Healthcare Conference
2022Senti Bio to Present at 41st Annual J.P. Morgan Healthcare Conference
2022Senti Bio Highlights Preclinical Data from Logic-Gated Gene Circuit CAR-NK Cell Therapy..
2022Senti Biosciences, Inc. Highlights Preclinical Data from Logic-Gated Gene Circuit CAR-N..
2022Senti Bio Highlights Preclinical Data from Logic-Gated Gene Circuit CAR-NK Cell Therapy..
2022Senti Bio to Host Investor Event Highlighting SENTI-202 at the 2022 ASH Annual Meeting
2022Senti Bio to Host Investor Event Highlighting SENTI-202 at the 2022 ASH Annual Meeting
2022Earnings Flash (SNTI) SENTI BIOSCIENCES Reports Q3 Revenue $1.6M
2022Senti Bio Reports Third Quarter Financial Results and Pipeline Updates
2022Senti Bio Reports Third Quarter Financial Results and Pipeline Updates
2022Senti Biosciences : Bio Reports Third Quarter Financial Results and Pipeline Updates - For..
2022Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
2022Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH Annual Meeting
2022Senti Bio Announces New Employment Inducement Grants
2022Senti Bio Announces New Employment Inducement Grants
2022Golden Grail Technology (GOGY) files to reduce its current authorized share count from ..
2022Top Premarket Decliners
2022Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at SITC..
2022Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at SITC..
2022Wall Street Set to Open Lower; Jobless Claims Fewer Than Expected; GDP Declines 0.6% in..
2022US Futures Lower Ahead of GDP, Jobless Reports
2022Top Premarket Gainers
2022Senti Bio to Participate in Chardan's 6th Annual Genetic Medicines Conference
2022US Futures Begin the Week Lower Ahead of Fed Meeting
2022Top Premarket Gainers
2022Senti Biosciences, Inc.(NasdaqGM:SNTI) added to S&P TMI..
2022Senti Bio to Present at Morgan Stanley 20th Annual Global Healthcare Conference
2022Chardan Announces Launch of ChEF (Chardan Equity Facility)
2022Senti Biosciences Announces New Employment Inducement Grants
2022Senti Biosciences Announces New Employment Inducement Grants
2022Senti Biosciences : Bio Reports Second Quarter Financial Results and Business Updates - Fo..
2022Earnings Flash (SNTI) SENTI BIOSCIENCES Posts Q2 Revenue $1.4M
2022Earnings Flash (SNTI) SENTI BIOSCIENCES Posts Q2 Revenue $1.36M
2022Senti Bio Reports Second Quarter Financial Results and Business Updates
2022Senti Bio Reports Second Quarter Financial Results and Business Updates
2022Top Premarket Decliners
2022Senti Biosciences Chief Operating Officer Curt Herberts Resigns
2022Senti Biosciences, Inc. Announces Resignation of Curt A. Herberts III, Chief Operating ..
2022Top Premarket Gainers
2022Top Premarket Gainers
2022Senti Biosciences, Inc. Announces Board Appointments
2022Senti Biosciences, Inc.(NasdaqGM:SNTI) added to NASDAQ ..
2022Senti Biosciences, Inc. cancelled the transaction announced on May 19, 2022
2022Senti Biosciences, Inc. announced that it has received $50.6 million in funding from a ..
2022Senti Biosciences, Inc. completed the acquisition of Dynamics Special Purpose Corp. fro..
2022Senti Biosciences, Inc. announced that it expects to receive $5.175 million in funding ..
2022Senti Biosciences, Inc. Auditor Raises 'Going Concern' Doubt
2022Senti Biosciences, Inc. Auditor Raises 'Going Concern' Doubt
2021Senti Biosciences, Inc. entered into a definitive business combination agreement to acq..
2021Senti Biosciences, Inc. announced that it expects to receive $66 million in funding fro..
2021Spark Therapeutics Enters Collaboration with Senti Bio to Bolster Industry-Leading Gene..